Intelligence

Home / Intelligence

Type
  • All
  • Blog
  • Briefs
  • Case Studies
  • Podcasts
  • Scientific Publications
  • Webinars
  • White Papers
Featured Topic
  • All
  • AIML
  • Analytics
  • APAC
  • Benchmarking
  • Biosimilars
  • CAR-T
  • Cell and Gene Therapy
  • Commercial Operations
  • Competitive Intelligence
  • Contract Analytics
  • Corporate Strategy
  • COVID-19
  • Data Management
  • Digital Therapeutics
  • Diversity
  • Emerging Life Sciences
  • Europe
  • Evidence Strategy (HEOR)
  • Field Force
  • Forecasting
  • Generative AI
  • Incentive Compensation
  • Inflation Reduction Act
  • Insights
  • International
  • LatAm
  • Launch and Brand Excellence
  • Learning and Development
  • Market Research
  • Marketing
  • MedTech
  • New Product Planning
  • NRDL
  • Omnichannel
  • Oncology
  • Patient Centricity
  • Patient Finding
  • Patient Services
  • Performance Tracking
  • Pricing and Access
  • Product Demos
  • Rare Disease
  • Real-World Evidence
  • Scientific Publications
  • Talent Acquisition and Retention
  • United States
Search

Webinars

Unlock the Potential of Generative AI in Life Sciences Insights and Operations

May 2, 2024 | 1:00 - 1:45 PM ET

Generative AI (GenAI) has created an opportunity to re-think and significantly improve how we work. GenAI has the potential to make pharma professionals far more effective and valuable to their organizations. Join us for “Making AI Real,” a webinar series dedicated to exploring how to leverage generative AI across different areas within pharmaceutical commercial operations and medical affairs.

Sign Up Now

Case Studies

Dynamic Targeting Solution

Client Situation A large biopharma customer wanted to develop a dynamic targeting solution for HCPs in a particular market Trinity’s Role Using machine learning, Trinity developed a model to predict HCPs’ future prescribing engagement Segmented prescribers into targeting tiers, updated on a quarterly basis Prioritized the prescriber tiers Project Outcomes Trinity delivered a model with 84% accuracy.* The solution supports a new, agile approach to call planning and execution to achieve better engagement using advanced analytics to dynamically target HCPs…

Read Now

Case Studies

NBA Insights Solution

Client Situation As part of an enterprise-wide Digital Transformation initiative, our client was looking to optimize effectiveness of marketing execution channels—and maximize clinical and commercial outcomes—by personalizing campaigns through engaging HCPs with the most relevant content (safety, efficacy, support, etc.) The client was first looking to scale an existing brand-specific NBA solution across all their inline brands. However, there were several challenges with the initial application and this approach: Basic, limited functionality with no prediction capability around sequential touchpoints High…

Read Now

Blog

Rise with the waves: Italy – AIFA restructuring and budget reforms – Stepping into a new (uncertain) future?

Published March 20, 2024

Executive Summary The Italian Medicines Agency (AIFA) underwent transformative changes on January 30, 2024, following a much-anticipated reorganization. AIFA’s restructuring has already faced challenges, with the recent resignation of the newly created Scientific and Economic Commission’s (CSE) chairman followed by the appointment of a new acting chairman, highlighting the need for a stable and collaborative leadership within AIFA.   Although AIFA’s overhaul has been implemented following a year-long delay due to bureaucratic complexities and is currently facing uncertainties, it will be…

Read Now

Case Studies

Rep-Centric Field Force Tool

Client Situation A midsize biopharma client wanted to create a rep-centric tool to help them understand their targets and map against current performance and gaps, identify changes in market scenario, manage schedules, prioritize targets and deliver contextual content Trinity’s Role Trinity developed a comprehensive field force tool to track target treatment paradigms, analyze market drivers and identify Next Best Actions (NBAs) ­Integrated tightly with rep calendars to provide triggers with insights and recommendations contextual to rep schedules ­Leveraged multiple data…

Read Now

Webinars

Annual State of Global Market Access Webinar

Available On Demand

Trinity Life Sciences is pleased to release our highly anticipated white paper, the Annual State of Global Market Access. This year’s white paper focuses on six key global market access trends and provides payer perspectives on these trends. We explore the consequences of new therapeutic advances and policies aiming to control costs globally and the impacts for pharma manufacturers. Register for this webinar for a deeper dive into a few trends in the white paper. Join experts from our Evidence,…

Watch Now

Case Studies

Next Best Engagement Recommendation System

Client Situation A large biopharma customer wanted to optimize their digital channel strategy and outreach to most effectively engage with HCPs Trinity’s Role Trinity developed an AI solution that predicts the next best digital channel, content and cadence to engage with individual HCPs Although originally created for one brand, the technology and AI model was crafted so that it could be scaled and easily configured to add different criteria and datasets After success with the initial brand, Trinity expanded the…

Read Now

White Papers

Annual State of Global Market Access

In 2023, the life sciences industry saw key therapeutic advances in sickle cell disease, obesity/weight management, and Duchenne muscular dystrophy, among others, and the continued approvals of therapies with cutting edge mechanisms, including the first CRISPR therapy. While 2022 was characterized by accelerated development processes and the rapid evolution of therapeutic standards, 2023 featured increased implementation of cost-effectiveness policies and the emergence of the consequences of these pricing controls and cost-effectiveness measures, including the Inflation Reduction Act (IRA) and Germany’s…

Read Now

Blog

Rise with the waves: Germany – A tale of two high impact policies shaping pharma’s future

Published February 26, 2024

Executive Summary Multiple cost-containment reforms, such as the introduction of a 20% rebate on brand-brand combinations and a temporary increase in the mandatory rebate on drugs to 12%, were implemented under Germany’s ‘Financial Stabilization of Statutory Health Insurance System’ Act (GKV-Finanzstabilisierungsgesetz) in 2023. The evaluation report of these strategies showed that the actual savings for the year fell short of the proposed target (25% deficit, €1.4 Bn vs. target of €1.9 Bn) for all such reforms except 30% higher savings…

Read Now

Blog

Cell and Gene Therapies: Six Global Trends We Are Watching in 2024

Published February 15, 2024

2023 was a busy year for cell and gene therapies (C&GT). There were regulatory approvals in the U.S. and EU, including both in rare pediatric conditions with no current effective options (e.g., Duchenne muscular dystrophy (DMD)), as well as in indications where competition is better established (e.g., hemophilia A and B). Towards the end of the year, the FDA approved not one, but two sickle cell gene therapies on the same day, creating instant competition between them. One of these…

Read Now

Webinars

Omnichannel Orchestration After Patient Finding: Once You’ve Found The Patients, What Do You Do?

Available On Demand

Across life sciences commercialization organizations, attention is shifting to best practices in strengthening the connection between healthcare professionals (HCPs) and patients. Join Susheel Sukhtankar, Partner and Head of Commercial Analytics at Trinity Life Sciences, as he hosts a dynamic discussion on the nuances of omnichannel orchestration with panelists Jerry Luciano, Vice President of Omnichannel Marketing at TGaS Advisors, a Division of Trinity Life Sciences, and Anushank Anand, Director of Omnichannel Analytics in Trinity’s Commercial Analytics practice. Key Webinar Topics Linking…

Watch Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.